The remote cardiac monitoring market in APAC is expected to grow from US$ 539.22 million in 2021 to US$ 3,746.28 million by 2028; it is estimated to grow at a CAGR of 31.9% from 2021 to 2028.
China, Japan, and India are major economies in APAC. Increase in incidence of cardiovascular diseases is the major factor driving the growth of the APAC remote cardiac monitoring market. Remote patient monitoring (RPM) allows patients to manage their health better by increasing their involvement in their health care. According to the World Health Organization (WHO), cardiovascular diseases (CVDs) are among the leading causes of death worldwide, and ~30 million people experience a stroke each year. Mortalities caused by CVDs in the Asia-Pacific countries range from less than 20% in countries such as Thailand, the Philippines, and Indonesia to 20–30% in urban China, Hong Kong, Japan, Korea, and Malaysia. Countries such as New Zealand, Australia, and Singapore have relatively high rates of 30–35%. Hypertension is a significant risk factor for CVD. RPM may serve as a vital conduit for improving hypertension control and reducing the economic burden stemming from prolonged or frequent hospital stays that result from acute hypertension-related events. Research has shown that RPM can significantly lower systolic blood pressure (SBP) and diastolic blood pressure (DBP) compared to usual care and self-monitoring alone. According to a few non-randomized trials, RPM can improve outcomes by enabling accurate and early detection as well as decreasing all-cause mortality rates and hospitalizations. Recent clinical guidelines strongly recommend the use of RPM for atrial fibrillation (AF) detection in both stroke and non-stroke patients, which is further anticipated to drive the Remote Cardiac Monitoring market in APAC.
The COVID-19 pandemic has critically influenced the region and has also allowed stakeholders to realign their future path based on strategic intent and focus. Moreover, various companies have been manufacturing patient monitoring devices with biosensors for easy and quick results. Reports have indicated that the usage of pulse oximeters in hospitals and at home has increased substantially amid this pandemic. The governments in a few countries are providing reimbursement for pulse oximeter purchases. For instance, in June 2020, the Union Health Ministry of India has decided to reimburse the cost of pulse oximeter purchased by beneficiaries Central Government Health Scheme (CGHS). They are tested positive as a supportive measure for COVID-19 patients monitoring at-home care during the pandemic.Moreover, in June 2021, Max Healthcare launched an artificial intelligence (AI)-powered device combined with a patient monitoring framework, declared the first in the nation. Max Healthcare has launched the service in partnership with MyHealthcare.Similarly, in February 2021, Remo Care Solutions (Kochi) launched Remo.Cardia a remote cardiac monitoring system powered by artificial intelligence that monitors and analyzes patients' vitals on a real-time basis. Thus, increasing government support and reimbursement policies for medical devices is expected to support the market of RPM devices.

- This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.
APAC Remote Cardiac Monitoring Market Segmentation
APAC Remote Cardiac Monitoring Market – By Product Type
- Devices
- Vital Signs Monitors
- Heart Rate Monitors
- Blood Pressure Monitors
- Breath Monitors
- Holter Monitors
- Others
- Software
- Cloud Based Software
- On-Premise Software
- Services
APAC Remote Cardiac Monitoring Market – By End User
- Hospitals and Clinics
- Emergency Settings
- Homecare Settings
- Others
APAC Remote Cardiac Monitoring Market– By Country
- Japan
- China
- India
- South Korea
- Australia
- RoAPAC
APAC Remote Cardiac Monitoring Market-Companies Mentioned
- Abbott
- Biotronik, Inc.
- Boston Scientific Corporation
- GE Healthcare
- Honeywell International Inc.
- Koninklijke Philips N.V.
- Medtronic
- Nihon Kohden Corporation
- OSI Systems, Inc.
Asia Pacific Remote Cardiac Monitoring Report Scope
Report Attribute | Details |
---|---|
Market size in 2021 | US$ 539.22 Million |
Market Size by 2028 | US$ 3,746.28 Million |
Global CAGR (2021 - 2028) | 31.9% |
Historical Data | 2019-2020 |
Forecast period | 2022-2028 |
Segments Covered |
By Product Type
|
Regions and Countries Covered | Asia-Pacific
|
Market leaders and key company profiles |
- Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
- PEST and SWOT Analysis
- Market Size Value / Volume - Global, Regional, Country
- Industry and Competitive Landscape
- Excel Dataset
Testimonials

I wish to appreciate your support and the professionalism you displayed in the course of attending to my request for information regarding to infectious disease IVD market in Nigeria. I appreciate your patience, your guidance, and the fact that you were willing to offer a discount, which eventually made it possible for us to close a deal. I look forward to engaging The Insight Partners in the future, all thanks to the impression you have created in me as a result of this first encounter.
DR CHIJIOKE ONYIA, MANAGING DIRECTOR, PineCrest Healthcare Ltd.
The Insight Partners delivered insightful, well-structured market research with strong domain expertise. Their team was professional and responsive throughout. The user-friendly website made accessing industry reports seamless. We highly recommend them for reliable, high-quality research services
Yukihiko Adachi CEO, Deep Blue, LLC.Reason to Buy
- Informed Decision-Making
- Understanding Market Dynamics
- Competitive Analysis
- Customer Insights
- Market Forecasts
- Risk Mitigation
- Strategic Planning
- Investment Justification
- Identifying Emerging Markets
- Enhancing Marketing Strategies
- Boosting Operational Efficiency
- Tracking Industry Innovations
- Aligning with Regulatory Trends
Yes! We provide a free sample of the report, which includes Report Scope (Table of Contents), report structure, and selected insights to help you assess the value of the full report. Please click on the "Download Sample" button or contact us to receive your copy.
Absolutely — analyst assistance is part of the package. You can connect with our analyst post-purchase to clarify report insights, methodology or discuss how the findings apply to your business needs.
Once your order is successfully placed, you will receive a confirmation email along with your invoice.
• For published reports: You’ll receive access to the report within 4–6 working hours via a secured email sent to your email.
• For upcoming reports: Your order will be recorded as a pre-booking. Our team will share the estimated release date and keep you informed of any updates. As soon as the report is published, it will be delivered to your registered email.
We offer customization options to align the report with your specific objectives. Whether you need deeper insights into a particular region, industry segment, competitor analysis, or data cut, our research team can tailor the report accordingly. Please share your requirements with us, and we’ll be happy to provide a customized proposal or scope.
The report is available in either PDF format or as an Excel dataset, depending on the license you choose.
The PDF version provides the full analysis and visuals in a ready-to-read format. The Excel dataset includes all underlying data tables for easy manipulation and further analysis.
Please review the license options at checkout or contact us to confirm which formats are included with your purchase.
Our payment process is fully secure and PCI-DSS compliant.
We use trusted and encrypted payment gateways to ensure that all transactions are protected with industry-standard SSL encryption. Your payment details are never stored on our servers and are handled securely by certified third-party processors.
You can make your purchase with confidence, knowing your personal and financial information is safe with us.
Yes, we do offer special pricing for bulk purchases.
If you're interested in purchasing multiple reports, we’re happy to provide a customized bundle offer or volume-based discount tailored to your needs. Please contact our sales team with the list of reports you’re considering, and we’ll share a personalized quote.
Yes, absolutely.
Our team is available to help you make an informed decision. Whether you have questions about the report’s scope, methodology, customization options, or which license suits you best, we’re here to assist. Please reach out to us at sales@theinsightpartners.com, and one of our representatives will get in touch promptly.
Yes, a billing invoice will be automatically generated and sent to your registered email upon successful completion of your purchase.
If you need the invoice in a specific format or require additional details (such as company name, GST, or VAT information), feel free to contact us, and we’ll be happy to assist.
Yes, certainly.
If you encounter any difficulties accessing or receiving your report, our support team is ready to assist you. Simply reach out to us via email or live chat with your order information, and we’ll ensure the issue is resolved quickly so you can access your report without interruption.















- Abbott
- Biotronik, Inc.
- Boston Scientific Corporation
- GE Healthcare
- Honeywell International Inc.
- Koninklijke Philips N.V.
- Medtronic
- Nihon Kohden Corporation
- OSI Systems, Inc.


